[1] |
国家人口计生委科技司. 12万例宫内节育器避孕效果调查报告[J]. 中国计划生育学杂志, 2007, 15(3):132-136. doi: 10.3969/j.issn.1004-8189.2007.03.001.
|
[2] |
Richter R. A means of preventing conception[J]. Dtsch Med Wochenschr, 1909, 35:1525-1527. Doi: 10.1055/s-0029-1201695.
|
[3] |
Lohr PA, Lyus R, Prager S. Use of intrauterine devices in nulliparous women[J]. Contraception, 2017, 95(6):529-537. doi: 10.1016/j.contraception.2016.08.011.
pmid: 27591814
|
[4] |
Dereje N, Engida B, Holland RP. Factors associated with intrauterine contraceptive device use among women of reproductive age group in Addis Ababa, Ethiopia: A case control study[J]. PLoS One, 2020, 15(2):e0229071. doi: 10.1371/journal.pone.0229071.
|
[5] |
Heinemann K, Reed S, Moehner S, et al. Risk of uterine perforation with levonorgestrel-releasing and copper intrauterine devices in the European Active Surveillance Study on Intrauterine Devices[J]. Contraception, 2015, 91(4):274-279. doi: 10.1016/j.contraception.2015.01.007.
pmid: 25601352
|
[6] |
Sano M, Nemoto K, Miura T, et al. Endoscopic Treatment of Intrauterine Device Migration into the Bladder with Stone Formation[J]. J Endourol Case Rep, 2017, 3(1):105-107. doi: 10.1089/cren.2017.0038.
pmid: 29082325
|
[7] |
Yang X, Duan X, Wu T. Ureteric Obstruction Caused by a Migrated Intrauterine Device[J]. Urol Case Rep, 2017, 10:33-35. doi: 10.1016/j.eucr.2016.11.011.
pmid: 27920988
|
[8] |
van Grootheest K, Sachs B, Harrison-Woolrych M, et al. Uterine perforation with the levonorgestrel-releasing intrauterine device: analysis of reports from four national pharmacovigilance centres[J]. Drug Saf, 2011, 34(1):83-88. doi: 10.2165/11585050-000000000-00000.
|
[9] |
Harrison-Woolrych M, Ashton J, Coulter D. Uterine perforation on intrauterine device insertion: is the incidence higher than previously reported?[J]. Contraception, 2003, 67(1):53-56. doi: 10.1016/s0010-7824(02)00417-1.
pmid: 12521659
|
[10] |
Barnett C, Moehner S, Do Minh T, et al. Perforation risk and intra-uterine devices: results of the EURAS-IUD 5-year extension study[J]. Eur J Contracept Reprod Health Care, 2017, 22(6):424-428. doi: 10.1080/13625187.2017.1412427.
pmid: 29322856
|
[11] |
Kaislasuo J, Suhonen S, Gissler M, et al. Uterine perforation caused by intrauterine devices: clinical course and treatment[J]. Hum Reprod, 2013, 28(6):1546-1551. doi: 10.1093/humrep/det074.
|
[12] |
Kho KA, Chamsy DJ. Perforated intraperitoneal intrauterine contraceptive devices: diagnosis, management, and clinical outcomes[J]. J Minim Invasive Gynecol, 2014, 21(4):596-601. doi: 10.1016/j.jmig.2013.12.123.
|
[13] |
Ortiz ME, Croxatto HB. Copper-T intrauterine device and levonorgestrel intrauterine system: biological bases of their mechanism of action[J]. Contraception, 2007, 75(Suppl 6):S16-S30. doi: 10.1016/j.contraception.2007.01.020.
|
[14] |
曹丽, 周毓青, 赵蔚, 等. 妇科急腹症1036例超声诊断与病理结果对照研究[J]. 中国实用妇科与产科杂志, 2008, 24(3):198-200. doi: 10.3969/j.issn.1005-2216.2008.03.016.
|
[15] |
卢单君, 林芙蓉, 张艳婷. 经腹部超声与经阴道超声联合检查在妇科急腹症诊断中的应用[J]. 中国妇幼保健, 2020, 35(4):764-766. doi:10.19829/j.zgfybj.issn.1001-4411.2020.04.057.
|
[16] |
杨华, 彭萍, 刘欣燕, 等. 宫内节育器嵌顿临床特点及诊疗方式[J]. 协和医学杂志, 2019, 10(4):364-366. doi :10.3969/j.issn.1674-9081.2019.04.010.
|
[17] |
蹇利梅, 郭曦, 傅博, 等. 多普勒彩超与MSCT在妇科急腹症患者诊断中的应用比较[J]. 中国CT和MRI杂志, 2021, 19(12):150-153. doi :10.3969/j.issn.1672-5131.2021.12.046.
|